The Therapeutic Goods Administration has added Raxone (idebenone) film coated tablets as a designated orphan drug.
Raxone is sponsored by TudorRose Consulting, and is indicated for the treatment of Duchenne muscular dystrophy.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 16
